Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) Operating Expenses (2016 - 2025)

Historic Operating Expenses for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $17.0 million.

  • InfuSystem Holdings' Operating Expenses rose 778.83% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.3 million, marking a year-over-year increase of 612.56%. This contributed to the annual value of $63.5 million for FY2024, which is 760.92% up from last year.
  • Latest data reveals that InfuSystem Holdings reported Operating Expenses of $17.0 million as of Q3 2025, which was up 778.83% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Operating Expenses ranged from a high of $18.5 million in Q1 2025 and a low of $12.0 million during Q4 2021
  • For the 5-year period, InfuSystem Holdings' Operating Expenses averaged around $15.2 million, with its median value being $15.3 million (2022).
  • Within the past 5 years, the most significant YoY rise in InfuSystem Holdings' Operating Expenses was 3151.07% (2021), while the steepest drop was 1368.81% (2021).
  • InfuSystem Holdings' Operating Expenses (Quarter) stood at $12.0 million in 2021, then grew by 8.25% to $13.0 million in 2022, then increased by 18.53% to $15.5 million in 2023, then increased by 0.9% to $15.6 million in 2024, then grew by 9.03% to $17.0 million in 2025.
  • Its Operating Expenses stands at $17.0 million for Q3 2025, versus $16.1 million for Q2 2025 and $18.5 million for Q1 2025.